Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083317
Filing Date
2025-06-06
Accepted
2025-06-06 17:57:25
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5973
  Complete submission text file 0000950170-25-083317.txt   7480
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Svoronos Dawn (Reporting) CIK: 0001574579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 251032302

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)